Top Tweets for #EMApresser
🤝 Tackling #GLP1 receptor agonist shortages requires everyone working together.
Let's protect the health of European patients.
#EMApresser
📊 EMA is conducting a real-world data study to understand off-label use better and refine our actions.
#GLP1 #EMApresser
📅 On 1 July, we will host a multistakeholder workshop to identify additional actions to address these shortages.
https://t.co/KCWcIyRvPK
#GLP1 #EMApresser
🗨️ Patients using GLP-1 receptor agonists should contact their doctors if their medication is unavailable. They can help find alternatives.
#GLP1 #EMApresser
🔔 These medicines are not miracle weight loss drugs and anyone interested in losing weight should discuss sustainable lifestyle changes with a doctor.
#GLP1 #EMApresser
🚫 Off-label use of GLP-1 receptor agonists for weight loss in people who do not have obesity or weight-related conditions is contributing to the shortage.
This needs to stop.🛑
#GLP1 #EMApresser
🩺Healthcare professionals and patients should be mindful about these medicines, and help prioritise patients who need them most.
#GLP1 #EMApresser
🌐EU countries should:
▶️ keep cooperating
▶️ consider controlling distribution where appropriate
▶️ work with healthcare professionals to develop clear therapeutic guidelines for prescribers
#GLP1 #EMApresser
🏭Companies should increase capacity and align promotional activities with public health goals.
#GLP1 #EMApresser
For this reason, we have just published recommendations to industry, regulators, healthcare professionals and patients to help tackle the shortages of #GLP1receptor agonists.
➡️ https://t.co/bqdi9pcXSx
#EMApresser
⏳ The situation will not resolve in 2024, it is complicated by many factors, and we need to make sure we all play our part to manage the shortages. This includes prescribers and consumers.
#GLP1 #EMApresser
💊 #GLP1 receptor agonists are authorised to treat #diabetes or #obesity. These conditions affect millions, making this a major public health concern.
#EMApresser
📈 Demand for #GLP1receptor agonists keeps growing and currently supply cannot keep up. Since 2022, shortages have occurred across 🇪🇺.
We must make sure patients who need these medicines most can access them.
#EMApresser
‼️ Follow EMA’s press briefing on GLP-1 receptor agonist shortages tomorrow
Live broadcast🔴 from 15:30 CET
#EMAPresser
👉 https://t.co/dARTk07ebp
Jedna trzecia wszystkich nowych leków, które w 2023 roku uzyskały pozytywną opinię była ukierunkowana na nowotwory. To daje 2⃣5⃣ nowych leków przeciwnowotworowych rekomendowanych do zatwierdzenia.
#EMAPresser
A third of all new medicines with a positive opinion in 2023 targeted cancer , i.e. 2⃣5⃣ new cancer medicines were recommended for approval last year.
#EMAPresser
#Cancer is an area where top innovation and scientific progress happen quickly. That’s why EMA decided to use this therapeutic area as a pathfinder to improve medicines evaluation overall. #EMAPresser
To support development and earlier assessment of medicines that address unmet medical needs for #cancer patients
➡️ 7 were reviewed in view of a conditional marketing authorisation
➡️ 1 had accelerated assessment
➡️ 2 were part of the #PRIME scheme
#EMAPresser
A third of all new medicines with a positive opinion in 2023 targeted cancer , i.e. 2⃣5⃣ new cancer medicines were recommended for approval last year.
#EMAPresser
We are committed to progressing treatments against #cancer and to supporting Europe’s beating cancer plan.
Cancer is an area of high unmet medical need and a major health concern in the 🇪🇺.
#EMAPresser #EUCancerPlan #HealthUnion
Last year, we also continued our work to tackle #COVID19, in particular with the evaluation of a new vaccine and 3 updated vaccines. 💉
#EMAPresser #COVID19Vaccines
Last Seen Hashtags on Sotwe
lady_riyadh
Seen from Germany
üniversitesi
Seen from Turkey
ทอมอยากโดนเย็ด
Seen from Thailand
HiFiUnicorn_1st_Anniversary
Seen from United States
minichat since:2026-10-15 until:2026-10-17 filter:videos
Seen from Australia
anxiouspanda
Seen from Brazil
臀模
Seen from India
soulinseoul
Seen from United States
anxiouspandq
Seen from Canada
막_다가와주세요
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers